Cargando…
Preoperative detection of KRAS G12D mutation in ctDNA is a powerful predictor for early recurrence of resectable PDAC patients
BACKGROUND: About 25–37% of resectable pancreatic ductal adenocarcinoma (PDAC) had a great chance of early recurrence after radical resection, which is mainly due to preoperative micrometastasis. We herein demonstrated the profiles of ctDNA in resectable PDAC and use of ctDNA to identify patients wi...
Autores principales: | Guo, Shiwei, Shi, Xiaohan, Shen, Jing, Gao, Suizhi, Wang, Huan, Shen, Shuo, Pan, Yaqi, Li, Bo, Xu, Xiongfei, Shao, Zhuo, Jin, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078253/ https://www.ncbi.nlm.nih.gov/pubmed/31969677 http://dx.doi.org/10.1038/s41416-019-0704-2 |
Ejemplares similares
-
Prognostic value of KRAS subtype in patients with PDAC undergoing radical resection
por: Dai, Manxiong, et al.
Publicado: (2022) -
Comparison of 4- and 4 plus-courses S-1 administration as adjuvant chemotherapy for pancreatic ductal adenocarcinoma
por: Li, Bo, et al.
Publicado: (2021) -
Targeting KRAS in PDAC: A New Way to Cure It?
por: He, Qianyu, et al.
Publicado: (2022) -
Modified artery-first approach for distal pancreatectomy with celiac axis resection
por: Wang, Huan, et al.
Publicado: (2023) -
Prediction of Tumor Cellularity in Resectable PDAC from Preoperative Computed Tomography Imaging
por: Jungmann, Friederike, et al.
Publicado: (2021)